Tag: VaccineCandidate

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Arcturus Therapeutics (NASDAQ: ARCT) Shares Fall After Analyst Downgrade Stock

financial buzz12/29/202012/29/2020

2156

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Arcturus Therapeutics Shares Fall After Analyst Downgrade Stock” Arcturus Therapeutics (NASDAQ: ARCT) plunged over 41% after analysts downgraded...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Arcturus Therapeutics Receives Approval from Health Sciences Authority to Proceed with Phase 2 Study of Vaccine Candidate

Danny Abramov12/29/2020

3638

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) reported approval from the Singapore Health Sciences Authority to commence its Phase 2 clinical study of its vaccine candidate ARCT-021. The study will...

Tag: VaccineCandidate

“The Buzz” Show: Arcturus Therapeutics (NASDAQ: ARCT) Shares Fall After Analyst Downgrade Stock

Arcturus Therapeutics Receives Approval from Health Sciences Authority to Proceed with Phase 2 Study of Vaccine Candidate

ABOUT US

Tweets